ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value

$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly stock-based compensation expense ($M) ($M)

Quarterly figures from Eli Lilly's filings and investor materials

Quarterly Annual

Latest, Q2 2026

201

Period ended Jun 30, 2026

Change on a year earlier

+8.6%

185 in Q2 2025

History

68 quarters

Since Q3 2008

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Stock-based compensation expense ($M) ($M)	Year on year	Source
Q2 2026	Jun 30, 2026	201	+8.6%	Form 10-Q (filed 2026-08-05) ↗
Q1 2026	Mar 31, 2026	161	+4.5%	Form 10-Q (filed 2026-04-30) ↗
Q4 2025	Dec 31, 2025	136	-4.4%	Form 10-K (filed 2026-02-12) ↗
Q3 2025	Sep 30, 2025	151	+13.3%	Form 10-Q (filed 2026-08-05) ↗
Q2 2025	Jun 30, 2025	185	-12.4%	Form 10-Q (filed 2026-08-05) ↗
Q1 2025	Mar 31, 2025	154	-3.4%	Form 10-Q (filed 2026-04-30) ↗
Q4 2024	Dec 31, 2024	142	+17.9%	Form 10-K (filed 2026-02-12) ↗
Q3 2024	Sep 30, 2024	133	-38.2%	Form 10-Q (filed 2024-10-30) ↗
Q2 2024	Jun 30, 2024	211	+30.7%	Form 10-Q (filed 2024-08-08) ↗
Q1 2024	Mar 31, 2024	159	+21.5%	Form 10-Q (filed 2024-04-30) ↗
Q4 2023	Dec 31, 2023	121	+29.9%	Form 10-K (filed 2026-02-12) ↗
Q3 2023	Sep 30, 2023	216	+153.3%	Form 10-Q (filed 2023-11-02) ↗
Q2 2023	Jun 30, 2023	162	+75.4%	Form 10-Q (filed 2023-08-08) ↗
Q1 2023	Mar 31, 2023	131	+29.9%	Form 10-Q (filed 2023-04-27) ↗
Q4 2022	Dec 31, 2022	92.9	+23.4%	Form 10-K (filed 2023-02-22) ↗
Q3 2022	Sep 30, 2022	85.1	-5.5%	Form 10-Q (filed 2022-11-01) ↗
Q2 2022	Jun 30, 2022	92.1	+0.2%	Form 10-Q (filed 2022-08-04) ↗
Q1 2022	Mar 31, 2022	101	+18.1%	Form 10-Q (filed 2022-04-29) ↗
Q4 2021	Dec 31, 2021	75.3	-14.2%	Form 10-K (filed 2022-02-23) ↗
Q3 2021	Sep 30, 2021	90.1	+25.7%	Form 10-Q (filed 2021-10-27) ↗
Q2 2021	Jun 30, 2021	91.9	+19.7%	Form 10-Q (filed 2021-08-03) ↗
Q1 2021	Mar 31, 2021	85.5	+19.1%	Form 10-Q (filed 2021-04-30) ↗
Q4 2020	Dec 31, 2020	87.8	+7.6%	Form 10-K (filed 2021-02-17) ↗
Q3 2020	Sep 30, 2020	71.7	-5.0%	Form 10-Q (filed 2020-10-28) ↗
Q2 2020	Jun 30, 2020	76.8	-3.4%	Form 10-Q (filed 2020-07-31) ↗
Q1 2020	Mar 31, 2020	71.8	-5.3%	Form 10-Q (filed 2020-05-01) ↗
Q4 2019	Dec 31, 2019	81.6	+12.1%	Form 10-K (filed 2020-02-19) ↗
Q3 2019	Sep 30, 2019	75.5	+10.2%	Form 10-Q (filed 2019-10-25) ↗
Q2 2019	Jun 30, 2019	79.5	+13.2%	Form 10-Q (filed 2019-08-02) ↗
Q1 2019	Mar 31, 2019	75.8	+11.5%	Form 10-Q (filed 2019-05-02) ↗
Q4 2018	Dec 31, 2018	72.8	+0.8%	Form 10-K (filed 2019-02-19) ↗
Q3 2018	Sep 30, 2018	68.5	-2.0%	Form 10-Q (filed 2018-11-06) ↗
Q2 2018	Jun 30, 2018	70.2	+0.4%	Form 10-Q (filed 2018-07-25) ↗
Q1 2018	Mar 31, 2018	68	-1.9%	Form 10-Q (filed 2018-04-27) ↗
Q4 2017	Dec 31, 2017	72.2	+8.1%	Form 10-K (filed 2018-02-20) ↗
Q3 2017	Sep 30, 2017	69.9	+13.7%	Form 10-Q (filed 2017-10-27) ↗
Q2 2017	Jun 30, 2017	69.9	+7.5%	Form 10-Q (filed 2017-07-28) ↗
Q1 2017	Mar 31, 2017	69.3	+11.8%	Form 10-Q (filed 2017-05-01) ↗
Q4 2016	Dec 31, 2016	66.8	+14.4%	Form 10-K (filed 2017-02-21) ↗
Q3 2016	Sep 30, 2016	61.5	+12.4%	Form 10-Q (filed 2016-10-28) ↗
Q2 2016	Jun 30, 2016	65	+16.5%	Form 10-Q (filed 2016-07-28) ↗
Q1 2016	Mar 31, 2016	62	+26.8%	Form 10-Q (filed 2016-04-29) ↗
Q4 2015	Dec 31, 2015	58.4	+43.8%	Form 10-K (filed 2016-02-19) ↗
Q3 2015	Sep 30, 2015	54.7	+42.1%	Form 10-Q (filed 2015-10-30) ↗
Q2 2015	Jun 30, 2015	55.8	+44.6%	Form 10-Q (filed 2015-07-30) ↗
Q1 2015	Mar 31, 2015	48.9	+27.7%	Form 10-Q (filed 2015-04-30) ↗
Q4 2014	Dec 31, 2014	40.6	–	Form 10-K (filed 2015-02-19) ↗
Q3 2014	Sep 30, 2014	38.5	–	Form 10-Q (filed 2014-10-29) ↗
Q2 2014	Jun 30, 2014	38.6	+14.5%	Form 10-Q (filed 2014-07-28) ↗
Q1 2014	Mar 31, 2014	38.3	+8.8%	Form 10-Q (filed 2014-04-28) ↗
Q2 2013	Jun 30, 2013	33.7	-3.2%	Form 10-Q (filed 2013-07-26) ↗
Q1 2013	Mar 31, 2013	35.2	+13.9%	Form 10-Q (filed 2013-04-26) ↗
Q4 2012	Dec 31, 2012	41.2	–	Form 10-K (filed 2013-02-21) ↗
Q3 2012	Sep 30, 2012	34.4	-52.7%	Form 10-Q (filed 2012-10-26) ↗
Q2 2012	Jun 30, 2012	34.8	–	Form 10-Q (filed 2012-07-27) ↗
Q1 2012	Mar 31, 2012	30.9	-18.5%	Form 10-Q (filed 2013-04-26) ↗
Q2 2011	Sep 30, 2011	72.8	+55.6%	Form 10-Q (filed 2011-10-28) ↗
Q1 2011	Mar 31, 2011	37.9	-48.6%	Form 10-Q (filed 2011-04-29) ↗
Q4 2010	Dec 31, 2010	55.8	-46.4%	Form 10-K (filed 2011-02-22) ↗
Q3 2010	Sep 30, 2010	46.8	-55.0%	Form 10-Q (filed 2010-10-29) ↗
Q2 2010	Jun 30, 2010	54.4	-42.3%	Form 10-Q/A (filed 2010-08-02) ↗
Q1 2010	Mar 31, 2010	73.7	-211.5%	Form 10-Q (filed 2011-04-29) ↗
Q4 2009	Dec 31, 2009	104	+66.3%	Form 10-K (filed 2011-02-22) ↗
Q3 2009	Sep 30, 2009	104	+33.5%	Form 10-Q (filed 2010-10-29) ↗
Q2 2009	Jun 30, 2009	94.3	–	Form 10-Q/A (filed 2010-08-02) ↗
Q1 2009	Mar 31, 2009	-66.1	–	Form 10-Q (filed 2010-04-30) ↗
Q4 2008	Dec 31, 2008	62.6	–	Form 10-K (filed 2011-02-22) ↗
Q3 2008	Sep 30, 2008	77.9	–	Form 10-Q (filed 2009-10-30) ↗

Cite this data

StockData. (2026). Eli Lilly Stock-based compensation expense ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_sbc_cf

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.